Should I buy Invesco (IVZ) stock or is it too late?

Invesco · Financials · price $29

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: RBC Capital — 73% of its targets hit on this sector (479 calls tested). It aims for $36 (+25 %), call made on October 10, 2026, maturing on October 10, 2027 (4 d ago).

The 6 reliable analysts $33+14 %

The 2 other firms $33+14 %

How to read it: the 6 reliable firms are not filtered by optimism — 6 aim above the price, 0 below, hence their $33 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Invesco

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
JP Morgan	73 %	+13.8 %	11	$30 +2%
Deutsche Bank	41 %	+11.4 %	29	$31 +7%
Keefe, Bruyette & Woods	58 %	+4.8 %	12	$20 -33%
Barclays	37 %	-11.8 %	19	$32 +11%
UBS	80 %	+29.2 %	5	—
Jefferies	67 %	+9.7 %	12	—
Credit Suisse	38 %	-6.7 %	8	—
Citigroup	37 %	-35.5 %	19	—

In short — Should you invest in Invesco? Is it too late, still worth it? Analysts are split (38% buy, median target $32, i.e. +11%), and the most reliable on IVZ targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $32, i.e. +11% from the current price ($29).
The most reliable firm on IVZ, Morgan Stanley (100% hit rate, 2 scored calls), targets $31 (call made on September 25, 2026, maturing on September 25, 2027) (+7%) in its most recent call, and $28 (call made on December 17, 2025, maturing on December 17, 2026) (-3%) in the one coming due soonest.
Pays a dividend (3.1% yield) — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 8 ratings, 5 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on IVZ

Median target $32 (+11%) · 8 ratings · Hold consensus

Strong Buy00%

Buy338%

Hold563%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Invesco now?

We won't decide for you. The facts: 38% of analysts rate it a buy, median target $32 (+11%), and Morgan Stanley (most reliable on IVZ, 100%) targets $31. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Invesco?

Not according to analysts: the median target ($32) is still +11% above the current price ($29) (most reliable on IVZ: Morgan Stanley, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Invesco still worth investing in?

It depends on the gap between the price ($29) and its estimated value: analysts target $32 on median (+11%), with 38% buys (most reliable on IVZ: Morgan Stanley, 100%). Cross-check with their real reliability on IVZ and the cautions above. Information, not advice.

What's the main risk in buying IVZ?

The consensus is not unanimous: of 8 ratings, 5 are neutral.

→ Go deeper: the full Invesco profile (consensus, analyst reliability, price target, performance).